Medicofarma Biotech SA (WSE:MDB)
Poland · Delayed Price · Currency is PLN 0.5040
+0.0020 (0.40%)
At close: Feb 11, 2026
Medicofarma Biotech Market Cap
Medicofarma Biotech has a market cap or net worth of 33.51 million as of February 12, 2026. Its market cap has increased by 23.87% in one year.
Market Cap
33.51M
Enterprise Value
36.81M
Revenue
281.45K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
Market Cap Chart
Since January 30, 2009, Medicofarma Biotech's market cap has increased from 6.50M to 33.51M, an increase of 415.59%. That is a compound annual growth rate of 10.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 33.51M | 23.56% |
| Dec 30, 2025 | 27.12M | 2.84% |
| Dec 30, 2024 | 26.38M | -64.24% |
| Dec 29, 2023 | 73.76M | -6.06% |
| Dec 30, 2022 | 78.51M | -32.05% |
| Dec 30, 2021 | 115.54M | 483.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.08B |
| NEUCA | 3.49B |
| Synektik Spólka Akcyjna | 2.54B |
| Voxel | 1.44B |
| Sygnis | 57.05M |
| BioMaxima | 54.09M |
| Pure Biologics | 44.30M |
| Pharmena | 38.98M |